Monensin, Ractopamine Hydrochloride Patent Expiration


About Veterinary Monensin, Ractopamine Hydrochloride

Monensin, Ractopamine Hydrochloride is used in drugs marketed by 3 different companies: Huvepharma Eood, Phibro Animal Health Corp, Elanco Us Inc.

Other drugs containing Monensin, Ractopamine Hydrochloride are: Topmax plus coban , Actogain and monovet , Optaflexx plus rumensin , Optigrid and monovet

Veterinary Monensin, Ractopamine Hydrochloride Patents

Given below is the list of patents protecting Monensin, Ractopamine Hydrochloride, along with the drug name that holds that patent and the company owning that drug.

Filter patents by

Drug Used In Drug Patent Number Drug Patent Expiry Drug Owner
Patent Data
Optaflexx Plus Rumensin US5631298 ELANCO US INC.

Monensin, Ractopamine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Monensin, Ractopamine Hydrochloride Generic API Manufacturers

Given below is the list of companies who have filed for Monensin, Ractopamine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.